This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Joseph Paul Marino, Jr: Innovator in Cytotoxicity Targeting
Introduction
Joseph Paul Marino, Jr. is an accomplished inventor based in Collegeville, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of targeted therapies.
Latest Patents
Marino holds a patent for "Cytotoxicity Targeting Chimeras for CCR2-Expressing Cells." This innovative approach aims to enhance the effectiveness of treatments for diseases associated with CCR2-expressing cells.
Career Highlights
He is currently associated with GlaxoSmithKline Intellectual Property Development Limited, where he continues to work on groundbreaking research and development projects. His expertise in the field has positioned him as a valuable asset to his organization.
Collaborations
Marino has collaborated with notable colleagues, including Jason W. Dodson and Peiling Chen, contributing to various projects that push the boundaries of current scientific understanding.
Conclusion
Joseph Paul Marino, Jr. exemplifies the spirit of innovation in biotechnology, with his work paving the way for advancements in targeted therapies. His contributions are vital to the ongoing evolution of medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile